Afqlir 40 mg/ml, injection solution

( ARTG ) AFQLIR (aflibercept) 2 mg is indicated in adults for the treatment of:, neovascular (wet) age-related macular degeneration (wet AMD), ​​​‍​​‍​​​​‍​​‍‍visual impairment due to macular oedema secondary to central retinal vein occlusion (CRVO), visual impairment due to macular oedema secondary to branch retinal vein occlusion (BRVO), diabetic macular oedema (DME), visual impairment due to myopic choroidal neovascularisation (myopic CNV).